Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells
Abstract Background Vasculogenic mimicry (VM) is characterized by the formation of tubular structure inside the tumor stroma. It has been shown that a small fraction of cancer cells, namely cancer stem cells (CSCs), could stimulate the development of vascular units in the tumor niche, leading to enh...
Main Authors: | Sanya Haiaty, Mohammad-Reza Rashidi, Maryam Akbarzadeh, Ahad Bazmany, Mostafa Mostafazadeh, Saba Nikanfar, Zohre Zibaei, Reza Rahbarghazi, Mohammad Nouri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-021-03246-w |
Similar Items
-
Vandetanib alters the tumoricidal capacity of human breast cancer stem cells via inhibiting vasculogenic capacity
by: Sanya Haiaty, et al.
Published: (2023-09-01) -
Correction to: Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells
by: Sanya Haiaty, et al.
Published: (2021-10-01) -
Vasculogenic mimicry persists during glioblastoma xenograft growth
by: Cong Li, et al.
Published: (2018-01-01) -
Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy
by: Mohammad Saleh Moulana, et al.
Published: (2024-03-01) -
Therapeutic potential of vasculogenic mimicry in urological tumors
by: Xinyu Lin, et al.
Published: (2023-09-01)